Unique proteomic features induced by a potential antiglioma agent, Nordy (dl-nordihydroguaiaretic acid), in glioma cells

Proteomics

Volumn 8, Issue 3, 2008, Pages 484-494

  Bian, Xiu Wu ^a   Xu, Jian Ping ^a   Ping, Yi Fang ^a   Wang, Yan ^a   Chen, Jian Hong ^a   Xu, Cheng Ping ^a   Wu, Yu Zhang ^a   Wu, Jun ^a   Zhou, Xiang Dong ^a   Chen, Yi Sheng ^a   Shi, Jing Quan ^a   Ji, Ming Wang ^b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Apoptosis; Differentiation therapy; Glioma; Lipoxygenase inhibitor; Proliferation

Indexed keywords

ALPHA ENOLASE; COFFILIN 1; CYCLOPHILIN; GALAPTIN; GLUTATHIONE TRANSFERASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INITIATION FACTOR 5A; NORDIHYDROGUAIARETIC ACID; PROTEIN ARGININE METHYLTRANSFERASE; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CARCINOGENICITY; CELL DIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; DRUG INHIBITION; GLIOMA; GROWTH INHIBITION; HUMAN; HUMAN CELL; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

AMINO ACID SEQUENCE; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; GLIOMA; HUMANS; LIPOXYGENASE INHIBITORS; MICE; MOLECULAR SEQUENCE DATA; NORDIHYDROGUAIARETIC ACID; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EUKARYOTA; MUS;

EID: 39149144060     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200700054     Document Type: Article

References (39)

1. Lakka, S. S., Gondi, C. S., Yanamandra, N., Olivero, W. C. et al., Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis. Oncogene 2004, 23, 4681-4689.
2. Kew, Y., Levin, V. A., Advances in gene therapy and immunotherapy for brain tumors. Curr. Opin. Neurol. 2003, 16, 665-670.
3. Scott, J. N., Rewcastle, N. B., Brasher, P. M., Fulton, D. et al., Long-term glioblastoma multiforme survivors: a population-based study. Can. J. Neurol. Sci. 1998, 25, 197-201.
4. Gupta, V.,Yi, Q. L., Brandwein, J., Lipton, J. H. et al., Role of all-trans-retinoic acid (ATRA) in the consolidation therapy of acute promyelocytic leukaemia (APL). Leuk. Res. 2005, 29,113-114.
5. Stockhausen, M. T., Sjolund, J., Manetopoulos, C., Axelson, H., Effects of the histone deacetylase inhibitor valproic acid on Notch signalling in human neuroblastoma cells. Br. J. Cancer 2005, 92, 751-759.
6. McDonald, R. W., Bunjobpon, W., Liu, T., Fessler, S. et al., Synthesis and anticancer activity of nordihydroguaiaretic acid (NDGA) and analogues. Anticancer Drug Des. 2001, 16, 261-270.
7. Bian, X., Shi, J., Xin, R., Effects of nordihydroguaiaretic acid on the growth and differentiation of SHG-44 glioma cell line. Zhonghua Bing Li Xue Za Zhi 1997, 26, 285-288.
8. Bian, X. W., Yang, S. X., Chen, J. H., Ping, Y. F et al., Preferential expression of the chemokine receptor CXCR4 by more highly malignant human gliomas and association with poor patient survival. Neurosurgery 2007, 61, 570-579.
9. Bian, X. W., Jiang, X. F., Chen, J. H., Bai, J. S. et al., Increased angiogenic capabilities of endothelial cells from microvessels of malignant human gliomas. Int. Immunopharmacol. 2006, 6, 90-99.
10. Chen, J. H., Bian, X. W., Yao, X. H., Gong, W. et al., Nordy, a synthetic lipoxygenase inhibitor, inhibits the expression of formylpeptide receptor and induces differentiation of malignant glioma cells. Biochem. Biophys. Res. Commun. 2006, 342, 1368-1374.
11. Bian, X., Chen, Z., Guo, D., Du, L. et al., Expression of angiogenic factors and cell cycle regulation factors in human glioblastoma cell line SHG-44. Zhonghua Bing Li Xue Za Zhi 1999, 28, 178-181.
12. Yang, S. X., Chen, J. H., Jiang, X. F., Wang, Q. L. et al., Activation of chemokine receptor CXCR4 in malignant glioma cells promotes the production of vascular endothelial growth factor. Biochem. Biophys. Res. Commun. 2005, 335, 523-528.
13. Hao, L. L., Mei, Q. B., Zhang, B. L., Jia, M., Li et al., PC-407 inhibited proliferation and induced apoptosis in human colon cancer SW-1116 cells. Acta Pharmacol Sin., 2004, 25, 1509-1514.
14. Gorg, A., Obermaier, C., Boguth, G., Harder, A. et al., The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis, 2000, 21, 1037-1053.
15. Mattow, J., Schmidt, F., Hohenwarter, W., Siejak, F. et al., Protein identification and tracking in two-dimensional electrophoretic gels by minimal protein identifiers. Proteomics, 2004, 4, 2927-2941.
16. Poon, H. F., Shepherd, H. M., Reed, T. T., Calabrese, V. et al., Proteomics analysis provides insight into caloric restriction mediated oxidation and expression of brain proteins associated with age-related impaired cellular processes: Mitochondrial dysfunction, glutamate dysregulation and impaired protein synthesis. Neurobiol. Aging 2006, 27, 1020-1034.
17. Beckner, M. E., Chen, X., An, J., Day, B. W., Pollack, I. F., Proteomic characterization of harvested pseudopodia with differential gel electrophoresis and specific antibodies. Lab. Invest. 2005, 85, 316-327.
18. Chen, J. H., Yao, X. H., Gong, W., Hu, J. et al., A novel lipoxygenase inhibitor Nordy attenuates malignant human glioma cell responses to chemotactic and growth stimulating factors. J. Neurooncol. 2007, 84, 223-231.
19. Zhou, Y., Bian, X., Le, Y., Gong, W. et al., Formylpeptide receptor FPR and the rapid growth of malignant human gliomas. J. Natl. Cancer Inst. 2005, 97, 823-835.
20. Moody, T. W., Leyton, J., Martinez, A., Hong, S. et al., Lipoxygenase inhibitors prevent lung carcinogenesis and inhibit non-small cell lung cancer growth. Exp. Lung Res. 1998, 24, 617-628.
21. Haraldsdottir, S., Guolaugsdottir, E., Ingolfsdottir, K., Ogmundsdottir, H. M., Anti-proliferative effects of lichen-derived lipoxygenase inhibitors on twelve human cancer cell lines of different tissue origin in vitro. Planta. Med., 2004, 70, 1098-1100.
22. Bian, X. W., Jiang, X. F., Chen, J. H., Bai, J. S. et al., Increased angiogenic capabilities of endothelial cells from microvessels of malignant human gliomas. Int. Immunopharmacol., 2006, 6, 90-99.
23. Wood, Z. A., Schroder, E., Robin-Harris, J., Poole, L. B., Structure, mechanism and regulation of peroxiredoxins. Trends Biochem. Sci., 2003, 28, 32-40.
24. Geiben-Lynn, R., Kursar, M., Brown, N. V., Addo, M. M. et al., HIV-1 antiviral activity of recombinant natural killer cell enhancing factors, NKEF-A and NKEF-B, members of the peroxiredoxin family. J. Biol. Chem., 2003, 278, 1569-1574.
25. Noh, D. Y., Ahn, S. J., Lee, R. A., Kim, S. W. et al., Overexpression of peroxiredoxin in human breast cancer. Anticancer Res, 2001, 21, 2085-2090.
26. Maeda, T., Furukawa, S., Transformation-associated changes in gene expression of alternative splicing regulatory factors in mouse fibroblast cells. Oncol. Rep. 2001, 8, 563-566.
27. Shimamura, T., Sakamoto, M., Ino, Y., Shimada, K. et al., Clinicopathological significance of galectin-3 expression in ductal adenocarcinoma of the pancreas. Clin. Cancer Res. 2002, 8, 2570-2575.
28. Biron, V. A., Iglesias, M. M., Troncoso, M. F., Besio-Moreno, M. et al., Galectin-1: biphasic growth regulation of Leydig tumor cells. Glycobiology, 2006, 16, 810-821.
29. Thompson, J. E., Hopkins, M. T., Taylor, C., Wang, T. W., Regulation of senescence by eukaryotic translation initiation factor 5A: implications for plant growth and development. Trends Plant Sci. 2004, 9, 174-179.
30. Zuk, D., Jacobson, A., A single amino acid substitution in yeast eIF-5A results in mRNA stabilization. EMBO J. 1998, 17, 2914-2925.
31. Moriyama, K., Yahara, I., Human CAP1 is a key factor in the recycling of cofilin and actin for rapid actin turnover. J. Cell Sci., 2002, 115, 1591-1601.
32. Dallaire, F., Dupuis, S., Fiset, S., Chabot, B., Heterogeneous nuclear ribonucleoprotein A1 and UP1 protect mammalian telomeric repeats and modulate telomere replication in vitro. J. Biol. Chem. 2000, 275, 14509-14516.
33. Xu, R. M., Jokhan, L., Cheng, X., Mayeda, A., Krainer, A. R., Crystal structure of human UP1, the domain of hnRNP A1 that contains two RNA-recognition motifs. Structure 1997, 5, 559-570.
34. Myers, J. C., Shamoo, Y., Human UP1 as a model for understanding purine recognition in the family of proteins containing the RNA recognition motif (RRM). J. Mol. Biol., 2004, 342, 743-756.
35. Mir, B., Tanner, N., Chowdhary, B. P., Piedrahita, J. A., UP1 extends life of primary porcine fetal fibroblasts in culture. Cloning Stem Cells 2003, 5, 143-148.
36. Nahreini, P., Hovland, A. R., Kumar, B., Andreatta, C. et al., Effects of altered cyclophilin A expression on growth and differentiation of human and mouse neuronal cells. Cell Mol. Neurobiol. 2001, 21, 65-79.
37. Bartolini, M., Andrisano, V., Wainer, I. W., Development and characterization of an immobilized enzyme reactor based on glyceraldehyde-3- phosphate dehydrogenase for on-line enzymatic studies. J. Chromatogr. A. 2003, 987, 331-340.
38. Prade, L., Huber, R., Manoharan, T. H., Fahl, W. E. et al., Structures of class pi glutathione S-transferase from human placenta in complex with substrate, transition-state analogue and inhibitor. Structure 1997, 5, 1287-1295.
39. Gajewska, J., Szczypka, M., Role of pi form of glutathione S-transferase (GST-pi) in cancer: a minireview. Mater. Med. Pol. 1992, 24, 45-49.